The page is the record's research on the issuer — no analyst, no rating, no view.

IDEAYA Biosciences, Inc. (IDYA) — research page

US · us-cm-kg/NASDAQ/IDYA · as of 2026-11-08

Identity and listing

IDEAYA Biosciences, Inc. is listed on NASDAQ under ticker IDYA. Its ISIN is US45166A1025 and its LEI is 549300ULW08F62IJML11. The security type is Corporate. The segment is not on the record. The sector is 2834 Pharmaceutical Preparations and the jurisdiction is United States, Delaware. The status is listed, not halted.

fieldvaluesource · read date
nameIDEAYA Biosciences, Inc.source · 2026-11-08
exchangeNASDAQsource · 2026-11-08
tickerIDYAsource · 2026-11-08
ISINUS45166A1025source · 2026-11-08
LEI549300ULW08F62IJML11source · 2026-11-08
security typeCorporatesource · 2026-11-08
segmentnot on the record
sector2834 Pharmaceutical Preparationssource · 2026-11-08
jurisdictionUnited States — Delawaresource · 2026-11-08
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 55 filings in the twelve months to 2026-11-08, on 32 filing days. The median gap between filing days is 8 days. The latest filing is dated 2026-11-03, 5 days before the record date, and is a regulatory filing. The NASDAQ median is 52 filings, 6.0 days of cadence gap and 5.0 days of latency across 4359 issuers. The sector median is 63.0 filings, 6.0 days of cadence gap and 4.0 days of latency across 526 issuers.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer5585
exchange median: NASDAQ (4359 issuers)5265
sector median: 2834 Pharmaceutical Preparations (526 issuers)6364
datetypecategoryfiling
2026-11-03regulatory_filingS-8S-8 — S-8
2026-11-03results10-Q10-Q — 10-Q
2026-11-03results8-K8-K — 8-K (items 2.02,9.01)
2026-10-08directors_dealings44 — FORM 4
2026-10-06regulatory_filing144144

window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor location is not on the record. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting or name change events. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The issuer is listed and not halted.

Orderability

The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, with the chapter as of 2026-11-04.

rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The issuer's investor-relations page names 18 research houses: BTIG, Cantor Fitzgerald, Citi, Citizens JMP, Goldman Sachs, Guggenheim Securities, Jefferies, JP Morgan, Leerink Partners LLC, LifeSci Capital, Mizuho Securities, RBC Capital Markets, Stifel, TD Securities, Truist Securities, UBS, Wedbush and William Blair.

research houseanalystsource · read date
BTIGJeet Mukherjeeissuer page · 2026-11-11
Cantor FitzgeraldLi Watsekissuer page · 2026-11-11
CitiYigal Nochomovitzissuer page · 2026-11-11
Citizens JMPSilvan Tuerkcanissuer page · 2026-11-11
Goldman SachsCorinne (Jenkins) Johnsonissuer page · 2026-11-11
Guggenheim SecuritiesPaul Jengissuer page · 2026-11-11
JefferiesMaury Raycroftissuer page · 2026-11-11
JP MorganAnupam Ramaissuer page · 2026-11-11
Leerink Partners LLCAndrew Berensissuer page · 2026-11-11
LifeSci CapitalCharles Zhuissuer page · 2026-11-11
Mizuho SecuritiesGraig Suvannavejhissuer page · 2026-11-11
RBC Capital MarketsLeonid Timashevissuer page · 2026-11-11
StifelLaura Prendergastissuer page · 2026-11-11
TD SecuritiesTyler Van Burenissuer page · 2026-11-11
Truist SecuritiesGregory J. Renzaissuer page · 2026-11-11
UBSMichael Yeeissuer page · 2026-11-11
WedbushRobert Driscollissuer page · 2026-11-11
William BlairAlethia Youngissuer page · 2026-11-11

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
10.2
https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)
10.3
https://data.sec.gov/submissions/CIK0001676725.json (identity.jurisdiction)
10.4
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.5
https://mcp.us-cm-kg.ai/events/NASDAQ/IDYA (the disclosure lines)
10.6
https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
10.7
https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
10.8
https://ir.ideayabio.com/analyst-coverage (coverage)
10.9
https://mcp.us-cm-kg.ai/record/NASDAQ/IDYA (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US45166A1025"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:9d27bd181f014cfe.